Nice | Rivaroxaban for treating PE and preventing recurrent embolism

2nd August 2013 by Louise Hudman

Another guideline about Rivaroxaban. Guidance was published in 2012 advising that Rivaroxaban could be used in the treatment of DVT. At that point, there was no guidance about its use in PEs. Since then a study has shown that it is as effective as Warfarin in the treatment of PE. Therefore this new guideline advises that Rivaroxaban can be used in the treatment of PE and for the prevention of recurrent PE and DVT.

Its main advantage is that it does not need monitoring. Its main disadvantage is that its effects are not easily reversible. It is also expensive.

 

Read for free

Sign up to access everything.

Free trial

Login

Already a member? Login to view this content.

Login

"I rely on the NASGP for advice and support. I use LocumDeck for all my locum admin -my profile, certificates, Ts and Cs, practice contacts, booking and invoicing sessions, pension A and B forms, recording mileage and other expenses and monthly earnings.

Having been a locum in the past without LocumDeck, I realise how much easier LocumDeck makes my life, especially as I don't enjoy admin. It automates much of the admin for me. I can see at a glance how many bookings I have and where the gaps are. I have some practices who instant book me - booking directly into free sessions I have added. I have income/expenditure spreadsheets to share with my accountant.

I would highly recommend it to others."

Dr Susannah Denny

See the full list of features within our NASGP membership plans

Membership